Reeve Emma
CIK 0001680329 Name as filed on the most recent filing
Filed as Reeve Emma (22)
56 transaction lines · from 22 filings · filed 2019-11-07 to 2026-01-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
56 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-05 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 734 disposed | 76.00 | 55,784.00 | Form 4, filing 0001680329-26-000002 | |
| 2025-12-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 733 disposed | 78.62 | 57,628.46 | Form 4, filing 0001680329-25-000014 | |
| 2025-11-21 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 10,000 disposed | 79.50 | 795,000.00 | Form 4, filing 0001680329-25-000012 | |
| 2025-11-12 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 7,333 disposed | 74.50 | 546,308.50 | Form 4, filing 0001680329-25-000010 | |
| 2025-10-30 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 12,000 disposed | 69.50 | 834,000.00 | Form 4, filing 0001680329-25-000008 | |
| 2025-10-30 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 3,666 disposed | 69.50 | 254,787.00 | Form 4, filing 0001680329-25-000008 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 4,591 disposed | 66.09 | 303,419.19 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 4,037 disposed | 66.10 | 266,845.70 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 3,149 disposed | 66.11 | 208,180.39 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 3,028 disposed | 65.09 | 197,092.52 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 2,729 disposed | 65.05 | 177,521.45 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 2,381 disposed | 66.87 | 159,217.47 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 2,163 disposed | 65.02 | 140,638.26 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,884 disposed | 66.89 | 126,020.76 | Form 4, filing 0001680329-25-000006 | |
| 2025-10-03 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,600 disposed | 66.93 | 107,088.00 | Form 4, filing 0001680329-25-000006 | |
| 2025-09-11 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 10,000 disposed | 59.50 | 595,000.00 | Form 4, filing 0001680329-25-000004 | |
| 2025-09-11 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 3,534 disposed | 59.50 | 210,273.00 | Form 4, filing 0001680329-25-000004 | |
| 2025-09-11 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,334 disposed | 59.50 | 79,373.00 | Form 4, filing 0001680329-25-000004 | |
| 2025-09-11 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 837 disposed | 59.50 | 49,801.50 | Form 4, filing 0001680329-25-000004 | |
| 2023-05-23 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,402 disposed | 59.54 | 83,472.00 | Form 4, filing 0001415889-23-008704 | |
| 2023-05-23 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,093 disposed | 59.53 | 65,068.48 | Form 4, filing 0001415889-23-008704 | |
| 2023-05-23 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 157 disposed | 59.52 | 9,344.18 | Form 4, filing 0001415889-23-008704 | |
| 2023-05-22 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 3,948 disposed | 59.53 | 235,029.57 | Form 4, filing 0001415889-23-008704 | |
| 2023-05-22 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 2,995 disposed | 59.53 | 178,302.83 | Form 4, filing 0001415889-23-008704 | |
| 2023-05-22 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 173 disposed | 59.52 | 10,297.69 | Form 4, filing 0001415889-23-008704 | |
| 2023-04-21 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 4,228 disposed | 55.04 | 232,701.09 | Form 4, filing 0001415889-23-006831 | |
| 2023-04-21 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 100 disposed | 55.57 | 5,557.00 | Form 4, filing 0001415889-23-006831 | |
| 2021-02-22 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 6,260 disposed | 37.60 | 235,373.50 | Form 4, filing 0001562180-21-001509 | |
| 2021-02-19 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 4,010 disposed | 37.71 | 151,217.90 | Form 4, filing 0001562180-21-001509 | |
| 2021-02-18 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 1,100 disposed | 37.58 | 41,343.06 | Form 4, filing 0001562180-21-001319 | |
| 2021-02-17 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 410 disposed | 37.56 | 15,397.84 | Form 4, filing 0001562180-21-001319 | |
| 2020-12-21 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 5,720 disposed | 35.11 | 200,805.18 | Form 4, filing 0001562180-20-007432 | |
| 2020-12-14 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 1,000 disposed | 68.00 | 68,000.00 | Form 4, filing 0001179110-20-011991 | |
| 2020-12-14 |
PTC Therapeutics, Inc. PTCT |
S, Open-market sale | 972 disposed | 68.00 | 66,096.00 | Form 4, filing 0001179110-20-011991 | |
| 2020-06-08 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 233 disposed | 38.35 | 8,936.46 | Form 4, filing 0001562180-20-004418 | |
| 2020-06-08 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 212 disposed | 36.59 | 7,757.23 | Form 4, filing 0001562180-20-004418 | |
| 2020-06-08 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 144 disposed | 37.67 | 5,423.88 | Form 4, filing 0001562180-20-004418 | |
| 2020-05-11 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 16,062 disposed | 49.53 | 795,623.14 | Form 4, filing 0001562180-20-003563 | |
| 2020-05-08 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 12,741 disposed | 49.53 | 631,055.36 | Form 4, filing 0001562180-20-003563 | |
| 2020-04-17 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 760 disposed | 35.29 | 26,819.64 | Form 4, filing 0001562180-20-003063 | |
| 2020-04-14 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 1,225 disposed | 35.20 | 43,122.70 | Form 4, filing 0001562180-20-003027 | |
| 2020-04-09 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 589 disposed | 35.02 | 20,625.54 | Form 4, filing 0001562180-20-002990 | |
| 2020-04-09 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 111 disposed | 35.02 | 3,886.99 | Form 4, filing 0001562180-20-002990 | |
| 2020-02-13 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 5,521 disposed | 35.06 | 193,539.21 | Form 4, filing 0001562180-20-001251 | |
| 2020-02-12 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 1,103 disposed | 35.02 | 38,623.97 | Form 4, filing 0001562180-20-001251 | |
| 2020-02-11 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 7,212 disposed | 35.04 | 252,708.48 | Form 4, filing 0001562180-20-001123 | |
| 2020-02-11 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 1,430 disposed | 35.04 | 50,107.20 | Form 4, filing 0001562180-20-001123 | |
| 2020-02-10 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 200 disposed | 35.00 | 7,000.00 | Form 4, filing 0001562180-20-001123 | |
| 2019-11-06 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 24,264 disposed | 18.40 | 446,518.26 | Form 4, filing 0001562180-19-005413 | |
| 2019-11-06 |
Constellation Pharmaceuticals Inc CNST |
S, Open-market sale | 15,740 disposed | 29.75 | 468,260.28 | Form 4, filing 0001562180-19-005413 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 56
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Reeve Emma, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001680329
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6